Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A2838 OSI-930Summary: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck
- A1835 Pelitinib (EKB-569)Summary: EGFR inhibitor,potent and irreversible
- A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
- A1186 AMG-208Summary: C-Met inhibitor,potent and highly selective
- A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent
- A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
- A5017 Motesanib Diphosphate (AMG-706)Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor
- A2822 AC480 (BMS-599626)Target: EGFRSummary: HER1/2 inhibitor,selective and efficacious
- A2974 Foretinib (GSK1363089)1 CitationSummary: VEGF and HGF receptor inhibitor
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor